GB201215675D0 - Compound - Google Patents

Compound

Info

Publication number
GB201215675D0
GB201215675D0 GBGB1215675.8A GB201215675A GB201215675D0 GB 201215675 D0 GB201215675 D0 GB 201215675D0 GB 201215675 A GB201215675 A GB 201215675A GB 201215675 D0 GB201215675 D0 GB 201215675D0
Authority
GB
United Kingdom
Prior art keywords
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1215675.8A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Exeter
Original Assignee
University of Exeter
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Exeter filed Critical University of Exeter
Priority to GBGB1215675.8A priority Critical patent/GB201215675D0/en
Publication of GB201215675D0 publication Critical patent/GB201215675D0/en
Priority to PCT/GB2013/052297 priority patent/WO2014033477A1/en
Priority to US14/425,385 priority patent/US9346758B2/en
Priority to AU2013308197A priority patent/AU2013308197B2/en
Priority to JP2015529127A priority patent/JP2015526499A/ja
Priority to SG11201501604TA priority patent/SG11201501604TA/en
Priority to RU2015111137A priority patent/RU2015111137A/ru
Priority to CN201380053228.0A priority patent/CN104718190B/zh
Priority to IN2514DEN2015 priority patent/IN2015DN02514A/en
Priority to CA2883754A priority patent/CA2883754A1/en
Priority to EP13771564.5A priority patent/EP2892881B1/en
Priority to MX2015002705A priority patent/MX2015002705A/es
Priority to BR112015004732A priority patent/BR112015004732A2/pt
Priority to KR1020157008471A priority patent/KR20150068374A/ko
Priority to ZA2015/02153A priority patent/ZA201502153B/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/69—Two or more oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/81—Preparation or application process involves irradiation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Birds (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
GBGB1215675.8A 2012-09-03 2012-09-03 Compound Ceased GB201215675D0 (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
GBGB1215675.8A GB201215675D0 (en) 2012-09-03 2012-09-03 Compound
KR1020157008471A KR20150068374A (ko) 2012-09-03 2013-09-02 광역학 치료에 사용하기 위한 피리디논 화합물
RU2015111137A RU2015111137A (ru) 2012-09-03 2013-09-02 Пиридиноновые соединения для применения в фотодинамической терапии
IN2514DEN2015 IN2015DN02514A (enExample) 2012-09-03 2013-09-02
AU2013308197A AU2013308197B2 (en) 2012-09-03 2013-09-02 Pyridinone compounds for use in photodynamic therapy
JP2015529127A JP2015526499A (ja) 2012-09-03 2013-09-02 光力学療法における使用のためのピリジノン化合物
SG11201501604TA SG11201501604TA (en) 2012-09-03 2013-09-02 Pyridinone compounds for use in photodynamic therapy
PCT/GB2013/052297 WO2014033477A1 (en) 2012-09-03 2013-09-02 Pyridinone compounds for use in photodynamic therapy
CN201380053228.0A CN104718190B (zh) 2012-09-03 2013-09-02 用于光动力疗法的吡啶酮化合物
US14/425,385 US9346758B2 (en) 2012-09-03 2013-09-02 Pyridinone compounds for use in photodynamic therapy
CA2883754A CA2883754A1 (en) 2012-09-03 2013-09-02 Pyridinone compounds for use in photodynamic therapy
EP13771564.5A EP2892881B1 (en) 2012-09-03 2013-09-02 Pyridinone compounds for use in photodynamic therapy
MX2015002705A MX2015002705A (es) 2012-09-03 2013-09-02 Compuestos de piridinona para usarse en terapia fotodinamica.
BR112015004732A BR112015004732A2 (pt) 2012-09-03 2013-09-02 composto de piridinona para uso em terapia fotodinâmica
ZA2015/02153A ZA201502153B (en) 2012-09-03 2015-03-30 Pyridinone compounds for use in photodynamic therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1215675.8A GB201215675D0 (en) 2012-09-03 2012-09-03 Compound

Publications (1)

Publication Number Publication Date
GB201215675D0 true GB201215675D0 (en) 2012-10-17

Family

ID=47075165

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1215675.8A Ceased GB201215675D0 (en) 2012-09-03 2012-09-03 Compound

Country Status (15)

Country Link
US (1) US9346758B2 (enExample)
EP (1) EP2892881B1 (enExample)
JP (1) JP2015526499A (enExample)
KR (1) KR20150068374A (enExample)
CN (1) CN104718190B (enExample)
AU (1) AU2013308197B2 (enExample)
BR (1) BR112015004732A2 (enExample)
CA (1) CA2883754A1 (enExample)
GB (1) GB201215675D0 (enExample)
IN (1) IN2015DN02514A (enExample)
MX (1) MX2015002705A (enExample)
RU (1) RU2015111137A (enExample)
SG (1) SG11201501604TA (enExample)
WO (1) WO2014033477A1 (enExample)
ZA (1) ZA201502153B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201215675D0 (en) 2012-09-03 2012-10-17 Univ Exeter Compound
EP3148528A1 (en) 2014-06-02 2017-04-05 University of Exeter Combinations of a photosensitizer with a hydrogen sulfide donor, thioredoxin inhibitor or nitroxide for use in photodynamic therapy
CN112062713B (zh) * 2020-08-04 2023-03-31 浙江工业大学 具铁螯合性和pdt活性的ala-hpo杂合衍生物及其制备方法与应用
KR102265592B1 (ko) * 2020-10-29 2021-06-17 김진왕 5-아미노레불린산 수화염화물을 포함하는 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9217099D0 (en) * 1992-08-12 1992-09-23 British Tech Group Pharmaceutical compositions
US5895786A (en) * 1996-05-08 1999-04-20 New York Blood Center, Inc. Method for treating viral infections
GB0018528D0 (en) * 2000-07-27 2000-09-13 Photocure Asa Compounds
GB201215675D0 (en) 2012-09-03 2012-10-17 Univ Exeter Compound

Also Published As

Publication number Publication date
ZA201502153B (en) 2017-07-26
IN2015DN02514A (enExample) 2015-09-11
AU2013308197B2 (en) 2018-02-01
EP2892881B1 (en) 2017-07-19
CN104718190B (zh) 2017-03-08
BR112015004732A2 (pt) 2018-04-17
RU2015111137A (ru) 2016-10-20
AU2013308197A1 (en) 2015-04-09
EP2892881A1 (en) 2015-07-15
CA2883754A1 (en) 2014-03-06
JP2015526499A (ja) 2015-09-10
MX2015002705A (es) 2015-12-01
KR20150068374A (ko) 2015-06-19
US9346758B2 (en) 2016-05-24
US20150210642A1 (en) 2015-07-30
CN104718190A (zh) 2015-06-17
WO2014033477A1 (en) 2014-03-06
SG11201501604TA (en) 2015-05-28

Similar Documents

Publication Publication Date Title
IL268013A (en) Tetrahydropyrazolopyrimidine compounds
IL237341A0 (en) Compounds that promote neurogenesis
SG11201403935VA (en) Imidazopyrrolidinone compounds
GB201209138D0 (en) Compounds
GB201215357D0 (en) Compounds
GB201214750D0 (en) Compounds
GB201220843D0 (en) Compound
EP2828262A4 (en) IMIDAZOTRIAZINONVERBINDUNGEN
GB201204985D0 (en) Compounds
GB201204125D0 (en) Compounds
ZA201500778B (en) Compounds
PT2836495T (pt) Compostos de tetra-hidropirrolotiazina
GB201209096D0 (en) Compounds
GB201219820D0 (en) Compounds
GB201216309D0 (en) Compound
GB201217310D0 (en) Compounds
GB201216448D0 (en) Compound
GB201222716D0 (en) Compound
GB201223429D0 (en) Compounds
GB201220029D0 (en) Compounds
GB201219819D0 (en) Compounds
GB201218799D0 (en) Compounds
GB201218774D0 (en) Compounds
GB201218776D0 (en) Compounds
GB201218018D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)